0241.HK

Online medical services provider Alibaba Health Information Technology Ltd. (0241.HK) said Wednesday its revenue rose 10.2% year-on-year to 14.27 billion yuan ($1.98 billion) in the six months through September. It credited the growth to a 67.5% jump in revenue from its pharmaceutical e-commerce platform business, which was partly offset by a 9.4% drop in revenue from its healthcare and digital services business.

The company’s net profit during the period, the first half of its fiscal year, surged by 72.5% to 770 million yuan. It attributed the strong gains to the revenue increase, as well as improving operational efficiencies for its self-operated pharmaceutical business, including its introduction of more top brands and expansion of its partnership channels.

The company’s stock rose 3.3% to HK$4.27 in early Thursday trade in Hong Kong.

By A. Au

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Zepp makes wearable products

Zepp hits its stride with return to revenue growth

The maker of low-end wearable devices reported its revenue rose 78.5% in the third quarter, but forecast the rate would ease to about 40% in the current quarter Key Takeaways:…
Man Wah subsidiary Remacro NEEQ listing

Man Wah sets spin-off in motion for its sofa tech unit

The Chinese furniture giant is preparing to list its components subsidiary Remacro to raise the technology unit’s profile and open an independent funding channel Key Takeaways: After listing on China’s…